Community Capital Management, LLC Bristol Myers Squibb CO Transaction History

Community Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	SELL	$0.13 - $76.84 $507 - $299,676	-3,900 Reduced 39.39%	6,000 $427,000
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $718,938 - $791,802	9,900 New	9,900 $762,000
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $841,991 - $981,564	-15,700 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $352,887 - $384,294	5,700 Added 57.0%	15,700 $1.05 Million
Q1 2021 May 04, 2021	SELL	$59.34 - $66.74 $534,060 - $600,660	-9,000 Reduced 47.37%	10,000 $631,000
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $140,885 - $159,649	2,440 Added 14.73%	19,000 $1.18 Million
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $438,067 - $571,419	8,902 Added 116.24%	16,560 $1.06 Million
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $327,532 - $388,337	7,658 New	7,658 $388,000
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $207,371 - $247,264	-4,596 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $224,100 - $290,605	4,596 New	4,596 $239,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Community Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Community Capital Management, LLC with notifications on news.